News

Good Morning Washington recently sat down with Dr. Patel, a double board-certified physician from Physicians Premiere Weight ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
Instant ramen maker Nissin Foods is leveraging the buzz around GLP-1s to launch in the US a trio of decadent tasting frozen ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
We view a Medifast revitalization as hinging on a steep coach network inflection. Read why we think MED stock becomes a core ...
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
Mark V. Sofonio, M.D., F.A.C.S., prescribes tailored mini procedures to help patients combat sagging skin caused by weight-loss drugs.
CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...